MBOT
What one share of Microbot Medical holds
Surgical and Medical Instruments and Apparatus
& Done® - Has the potential to be compatible with our NovaCross® products or possibly other instruments that combines guidewire and microcatheter into a single device. We are currently evaluating this combination in different applications.
Microbot Medical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.26 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.29 |
| Cash and investments | $1.00 |
| Book value | $1.03 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | $5.99 | $0.03 | −$0.85 | — | $1.61 |
| 2018 | — | −$2.41 | $0.08 | −$1.91 | — | $0.44 |
| 2019 | — | −$1.70 | $0.05 | −$1.56 | — | $4.39 |
| 2020 | — | −$1.29 | $0.01 | −$1.03 | — | $3.42 |
| 2021 | — | −$1.59 | $0.01 | −$1.33 | — | $2.02 |
| 2022 | — | −$1.81 | $0.01 | −$1.60 | — | $0.92 |
| 2023 | — | −$1.05 | $0.00 | −$0.84 | — | $0.38 |
| 2024 | — | −$0.73 | $0.00 | −$0.57 | — | $0.18 |
| 2025 | — | −$0.29 | $0.00 | −$0.29 | — | $1.15 |